Medicare AdvantageCoverageMedium impact
MA05.047p, Treatment of Obstructive Sleep Apnea (OSA) and Primary Snoring in Adults
Independence Blue Cross·Sleep Medicine, Pulmonology, ENT (Ear, Nose & Throat)·Medical Policy
Effective date
Jan 1, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA05.047p for Treatment of Obstructive Sleep Apnea (OSA) and Primary Snoring in Adults has been updated with an effective date of January 1, 2026. This is a fresh policy change that may affect coverage criteria, billing requirements, or documentation standards for sleep apnea treatments.
Action Required
Before January 1, 2026: Billing team should review the complete MA05.047p policy document at the IBX website to identify specific changes to coverage criteria, prior authorization requirements, or billing guidelines for OSA and primary snoring treatments. Update billing workflows and provider documentation requirements accordingly once full policy details are reviewed.